The primary purpose of Clinical and Translational Research Services (CTRS) is to facilitate, support, and assure the generation and conduct of high impact patient research in the most efficient and safe way possible to substantially reduce the burden of cancer for the people of Hawai'i and elsewhere. Reducing the disparate burden of cancer experienced by certain minorities and vulnerable populations is a primary goal. In the absence of a university hospital, CTRS has provided the infrastructure to give Hawai'i's community-based providers and the patients they serve access to NCI/NIH-sponsored clinical trials from Minority-based Clinical Oncology Program (MB-CCOP), National Surgical Adjuvant Breast and Bowel Project (NSABP) and research project grants. These trials have provided Hawai'i patients with access to the most promising research opportunities and contribute Hawai'i's unique multi-ethnic population to large multicenter clinical trials. Furthermore, the system maintains cancer care providers at the cutting edge of state-of-the-science care through their participation in the research and the associated continuing education activities of the system. This assures that in most cases patients can access the best care without having to leave the islands and reduces the chance of patients incurring additional costs to travel more than 2500 miles for care, or be separated from their families and social support systems while receiving cancer care. CTRS supports a level of community access and dissemination for clinical and translational research that is seldom seen at other NCI-designated cancer centers. In the absence of a university medical center, all clinical investigation is conducted through community-based providers. This gives unparalleled opportunity to accelerate the progression of discoveries from bench to bedside to community application. With the formation of the Hawai'i Cancer Consortium (HCC) this year, the University of Hawai'i Cancer Center (UHCC) will develop a vibrant clinical and translational research activity of investigator-initiated protocols. CTRS will support the development and conduct of these protocols as a first priority to rapidly translate discoveries of the UHCC's research programs into community-based clinical applications. A large component of CTRS is committed to facilitating the participation of underserved minorities in clinical trials. We have made substantial progress in this respect. Usually more than 200 new subjects each year are enrolled on cancer clinical trials of all phases, with proportional representation of Hawai'i's ethnic minorities. Native Hawaiians and other Pacific Islanders, who represent about 12% of all cancer patients and experience the worst cancer outcome, constitute 25% of patients enrolled.

Public Health Relevance

This shared resource provides the infrastructure to support the participation of Hawai'i cancer patients in NCI-sponsored clinical trials to substantially reduce the burden of cancer for the people of Hawai'i and elsewhere.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA071789-14S2
Application #
8724382
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
14
Fiscal Year
2013
Total Cost
$4,214
Indirect Cost
$1,423
Name
University of Hawaii
Department
Type
DUNS #
965088057
City
Honolulu
State
HI
Country
United States
Zip Code
96822
Gong, J; Nishimura, K K; Fernandez-Rhodes, L et al. (2018) Trans-ethnic analysis of metabochip data identifies two new loci associated with BMI. Int J Obes (Lond) 42:384-390
Pokhrel, Pallav; Herzog, Thaddeus A; Fagan, Pebbles et al. (2018) E-cigarette Advertising Exposure, Explicit and Implicit Harm Perceptions, and E-Cigarette use Susceptibility Among Non-Smoking Young Adults. Nicotine Tob Res :
Wu, Eric M; Hernandez, Brenda Y; Wong, Linda L (2018) Hepatocellular carcinoma in Micronesians, a growing Pacific Islander population in the U.S. Open J Gastroenterol 8:
Murphy, Sharon E; von Weymarn, Linda B; Parenteau, Marc et al. (2018) Influence of UGT2B10 Genotype on Urinary Excretion of 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol- N-glucuronide by African American Smokers. Chem Res Toxicol 31:168-175
Loo, Lenora W M; Williams, Makana; Hernandez, Brenda Y (2018) The high and heterogeneous burden of breast cancer in Hawaii: A unique multiethnic U.S. Population. Cancer Epidemiol 58:71-76
Hernandez, Brenda Y; Tareg, Aileen C; Reichhardt, Martina et al. (2018) Randomized controlled trial evaluating the utility of urine HPV DNA for cervical cancer screening in a Pacific Island population. J Glob Health Rep 2:
Gu, Yuanzhuo; Wei, Xiyang; Sun, Yulin et al. (2018) miR-192-5p silencing by genetic aberrations is a key event in hepatocellular carcinomas with cancer stem cell features. Cancer Res :
Lim, Unhee; Monroe, Kristine R; Buchthal, Steve et al. (2018) Propensity for Intra-abdominal and Hepatic Adiposity Varies Among Ethnic Groups. Gastroenterology :
Maskarinec, Gertraud; Ju, Dan; Fong, Jaimie et al. (2018) Mammographic density and breast tissue expression of inflammatory markers, growth factors, and vimentin. BMC Cancer 18:1191
Amshoff, Yvette; Maskarinec, Gertraud; Shvetsov, Yurii B et al. (2018) Type 2 diabetes and colorectal cancer survival: The multiethnic cohort. Int J Cancer 143:263-268

Showing the most recent 10 out of 562 publications